S. Lambaki

Volumetric and MGMT parameters in glioblastoma patients: Survival analysis

George Fountzilas, Georgios Iliadis, P. Selviaridis, 2012, BMC Cancer.

Prognostic and predictive value of p-Akt, EGFR, and p-mTOR in early breast cancer

G. Lazaridis, G. Fountzilas, G. Pentheroudakis, 2014, Strahlentherapie und Onkologie.

Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG).

M. Dimopoulos, K. Syrigos, H. Kalofonos, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

STAT-Related Profiles Are Associated with Patient Response to Targeted Treatments in Locally Advanced SCCHN.

K. Syrigos, G. Fountzilas, K. Markou, 2011, Translational oncology.

9088 Phase III study of Lipoplatin plus Gemcitabine versus Cisplatin plus Gemcitabine in advanced NSCLC; interim analysis

C. Kosmas, A. Athanasiou, S. Lambaki, 2009 .

A phase I study of temozolomide and lapatinib combination in patients with recurrent high-grade gliomas

G. Fountzilas, G. Pentheroudakis, V. Karavasilis, 2013, Journal of Neurology.

Volumetric and MGMT parameters in glioblastoma patients: Survival analysis

P. Selviaridis, G. Fountzilas, A. Eleftheraki, 2012, BMC Cancer.